Fundraising Fox
/Companies
Sign in

Relation Therapeutics

Miami Beach, US · Founded 2021 · 7 known investors

Find your way into Relation Therapeutics

Sign up to see every warm intro you have to Relation Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Relation Therapeutics team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Drug discovery company combining AI, genomics, and lab-in-the-loop for disease mapping

Biotech

Founders & leadership

DRDavid Roblin
David RoblinExecutive
CB
Casey Benjamin SwernerExecutive

Board

CR
Charles RobertsBoard director
JP
Jason PontinBoard director
JM
Jim MellonBoard director
CA
Christine AylwardBoard director

Investors · 7

DCVC (Data Collective)reportedPalo Alto · $5M – $25M

How we know: a partner's Signal profile · board seat on SEC Form D · globenewswire.com · funding news · Not right? Tell us

Deerfield Management CompanyreportedNew York

How we know: globenewswire.com · Not right? Tell us

Khosla VenturesreportedMenlo Park · $100K – $20M

How we know: globenewswire.com · Not right? Tell us

Magnetic VenturesreportedBoston · $1M – $6M

How we know: a partner's Signal profile · board seat on SEC Form D · globenewswire.com · Not right? Tell us

Also in the syndicate · 2

ARK InvestNVentureslead

Reported raises · per SEC filings

Form D private placements

$116.4M disclosed across 5 rounds · 2021–2025

▶$36.2MraisedDec 2025 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David RoblinExecutive Officer, Director
  • Charles RobertsDirector
  • Jason PontinDirector
  • Jim MellonDirector
  • Christine AylwardDirector
  • Casey Benjamin SwernerExecutive Officer
Offering amount
$36.2M
Amount sold
$36.2M
First sale
Nov 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedDec 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jim MellonDirector
  • David RoblinDirector
  • Jason PontinDirector
  • Christine AylwardDirector
  • Charles RobertsDirector
  • Casey Benjamin SwernerExecutive Officer
Offering amount
$15M
Amount sold
$15M
First sale
Nov 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40.3MraisedJan 2024 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christine AylwardDirector
  • Jim MellonDirector
  • Jason PontinDirector
  • Casey SwernerExecutive Officer
  • David RoblinExecutive Officer, Director
  • Charles RobertsDirector
Offering amount
$51.7M
Amount sold
$40.3M
First sale
Jan 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16MraisedJun 2022 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • CHARLES ROBERTSDirector
  • CASEY BENJAMIN SWERNERExecutive Officer
  • DAVID ROBLINDirector
  • CHRISTINE AYLWARDDirector
  • JASON PONTINDirector
  • JIM MELLONDirector
Offering amount
$16M
Amount sold
$16M
First sale
May 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9MraisedAug 2021 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • DAVID ROBLINDirector
  • CASEY BENJAMIN SWERNERExecutive Officer
  • CHARLES ROBERTSDirector
Offering amount
$9M
Amount sold
$9M
First sale
Jul 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Relation Therapeutics do?
Drug discovery company combining AI, genomics, and lab-in-the-loop for disease mapping
Who are Relation Therapeutics's investors?
Relation Therapeutics's investors include Hitachi Ventures, DCVC (Data Collective), Deerfield Management Company, Khosla Ventures, Magnetic Ventures.
How much funding has Relation Therapeutics raised?
Relation Therapeutics has disclosed $116.4M raised across 5 rounds.
Where is Relation Therapeutics headquartered?
Relation Therapeutics is headquartered in Miami Beach, US.